Lido Advisors
CYTK icon

Lido Advisors’s Cytokinetics CYTK Stock Holding History

Lido Advisors’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-11,004
Closed -$134K – 247
2016
Q4 		$134K Buy
11,004
+480
+5% +$5.09K 0.03% 205
2016
Q3 		$97K Hold
10,524
– – 0.03% 145
2016
Q2 		$100K Buy
10,524
+524
+5% +$4.3K 0.03% 151
2016
Q1 		$70K Buy
+10,000
New +$73.1K 0.02% 144

Other funds holding CYTK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Lido Advisors's CYTK Position: Q1 2017 in Review

Lido Advisors sold out of Cytokinetics (CYTK) in Q1 2017, closing a stake of 11,004 shares — an estimated $134K sold.

Lido Advisors first reported a position in CYTK in Q1 2016 and held it in 4 quarters. The position peaked at $134K in Q4 2016. 108 funds tracked by Wall St. Rank hold CYTK as of Q1 2017.

  • Lido Advisors reported no remaining Cytokinetics position as of Q1 2017 after selling out during the quarter.
  • Lido Advisors sold 11,004 Cytokinetics shares in Q1 2017, an estimated $134K.
  • Lido Advisors first reported a position in Cytokinetics in Q1 2016 and held it in 4 quarters.
  • Lido Advisors's Cytokinetics position peaked at $134K in Q4 2016.
  • 108 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2017.

Based on Lido Advisors's 13F filing for Q1 2017, filed 15 May 2017.